Search
Nanomedicine Breakthrough Could Improve Chemotherapy for Childhood Cancer
- OPACC
- Nov 20, 2012
- 1 min read
In a world-first, researchers from the Australian Centre for Nanomedicine at the University of New South Wales (UNSW) in Sydney have developed a nanoparticle that could improve the effectiveness of chemotherapy for neuroblastoma by a factor of five.
Recent Posts
See AllAmong pediatric patients with hematologic malignancies undergoing hematopoietic stem cell transplantation (HSCT), using...
Neuroblastomas are the most common cancer in infants, with about 700–800 diagnoses per year in the US, according to the American Cancer...
Childhood cancer survivors are more likely than the general population to develop chronic health conditions and die before reaching 65...